Skip to content

Hypnosis vs Midazolam for Sedation for TEE

Hypnosis for Sedation in Transesophageal Echocardiography: Comparison With Midazolam

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01749475
Enrollment
98
Registered
2012-12-13
Start date
2010-06-30
Completion date
2010-09-30
Last updated
2013-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Indications for Transesophageal Echocardiography

Brief summary

Most of the reports on hypnosis in the literature have focused on pain control during minor operations. With this study we aimed to evaluate the role of hypnosis on sedation for transesophageal echocardiography and compare it with commonly used sedative midazolam.

Interventions

DRUGMidazolam

The patients will be given 0.05mg/kg iv midazolam just before monitorization. During probing, in case of intolerance to the insertion of the probe, the increments of midazolam with 0.005mg/kg doses will be given.

OTHERhypnotherapy

A first hypnotic induction will be carried out the day before the procedure, next day, fifteen minutes before the procedure, a new induction will be performed.

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* indications for TEE * American Society of Anesthesiology (ASA) physical status I-III

Exclusion criteria

* mental illness, * psychotropic medication use, * hypersensitivity to drugs * a body mass index over 30.

Design outcomes

Primary

MeasureTime frame
Sedative effects of hypnotherapy and the drug midazolam indicated by anxiety scores and bispectral index (BIS) monitoringduring transesophageal echocardiography

Secondary

MeasureTime frame
measurement of alertness after sedation with continuous performance test (CPT)the same time frame

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026